Friday, October 22, 2010


Botox Shots Approved for Migraine

The Food and Drug Administration on Friday approved Botox, the anti-wrinkle shot from Allergan, as a treatment to prevent chronic migraines.....

The agency’s decision endorses doctors’ use of Botox to treat patients who suffer from a severe form of migraine involving headaches on at least 15 days a month. Britain’sdrug agency approved Botox for the same use this summer.

Botox is already approved by the F.D.A. to treat uncontrolled blinking; crossed eyes; certain neck muscle spasms; excessive underarm sweating; and stiffness associated with muscle spasticity in the elbows and hands. It also is approved for cosmetic purposes — to smooth lines between the eyebrows.




http://www.nytimes.com/2010/10/16/health/16drug.html

Wednesday, October 13, 2010

Secondary Smoke Linked to ADHD in Children

By Rick Nauert PhD Senior News Editor
Reviewed by John M. Grohol, Psy.D. on October 11, 2010

Secondary Smoke Linked to ADHD in Children


New research suggests children exposed to secondhand smoke are at risk to develop a variety of mental and physical health problems.

Investigators presented findings that show significantly higher rates of attention deficit hyperactivity disorder (ADHD), headaches and stuttering among children exposed to secondhand smoke than those who are not exposed.

Shttp://psychcentral.com/news/2010/10/11/secondary-smoke-linked-to-adhd-in-children/19456.html